BMO Capital Maintains Outperform on Constellium, Raises Price Target to $22
Portfolio Pulse from richadhand@benzinga.com
BMO Capital analyst David Gagliano has maintained an Outperform rating on Constellium (NYSE:CSTM) and raised the price target from $20 to $22.
July 27, 2023 | 1:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Constellium's price target has been raised from $20 to $22 by BMO Capital, maintaining an Outperform rating.
The raised price target and maintained Outperform rating by BMO Capital indicates a positive outlook for Constellium. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100